QSAR study, molecular docking, and ADMET prediction of vinyl sulfone-containing Nrf2 activator derivatives for treating Parkinson disease

Tong, Jianbo; Wang, Jie; Luo, Ding; Xiao, Xuechun; Xu, Hai-Yin; Bian, Shuai; Zhang, Xing

doi:10.1007/s11224-022-01909-z

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Book1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease

Ajala,

Eltayb,

Abatyough

et al. 2024

Intelligent Pharmacy

View full text Add to dashboard Cite

In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease

Ajala,

Eltayb,

Abatyough

et al. 2024

Intelligent Pharmacy

View full text Add to dashboard Cite

Improved SAR and QSAR models of SARS-CoV-2 Mpro inhibitors based on machine learning

Tong,

Gao,

et al. 2024

Journal of Molecular Liquids

View full text Add to dashboard Cite

Scope of Theoretical Approaches Studying the Ligand-Nrf2 Interactions

A. Soriano-Ursúa,

L. Ocampo-Néstor,

N. Rosalez

et al. 2024

The Role of NRF2 Transcription Factor [Working Title]

View full text Add to dashboard Cite

The nuclear factor erythroid 2-related factor 2 (Nrf2) is a protein transcriptional factor considered as an emerging target for multiple biological processes. Its study could be useful to develop new treatments. Theoretical approaches have led to investigating the relevance of nuanced details in the structure of that protein. Also, after the X-ray crystals reporting Nrf2-KEAP1 interactions and identification of sites for potential interaction of other proteins and small compounds, the number of reports regarding these interactions is increasing. In this chapter, the advancements of theoretical approaches were collected and presented as useful to apply for developing therapeutic tools. First, information regarding the structure of Nrf2, as well as the observed interactions in crystal complexes is presented and commented. Thereafter, the identified sites of interest for letting interactions of natural compounds or small drugs which are proposed as potential drugs are presented. Finally, the advances and limitations of the theoretical assays, as well as the relationship with data reported experimental assays and the potential applications in medicine, are stated. Updated advancements by application of theoretical approach for understanding ligand interactions on Nrf2 are helpful to understand the biological activity of Nrf2 and the origin of some fails involved in etiology and pathophysiology of some human diseases.

show abstract

QSAR study, molecular docking, and ADMET prediction of vinyl sulfone-containing Nrf2 activator derivatives for treating Parkinson disease

Cited by 3 publications

References 55 publications

In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease

In-silico screening and ADMET evaluation of therapeutic MAO-B inhibitors against Parkinson disease

Improved SAR and QSAR models of SARS-CoV-2 Mpro inhibitors based on machine learning

Scope of Theoretical Approaches Studying the Ligand-Nrf2 Interactions

Contact Info

Product

Resources

About